Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Mary G. Leonard"'
Publikováno v:
European Journal of Pharmacology. 789:81-87
Centhaquin has been shown to produce antinociception in the mouse hot plate and tail flick assays through the opioid, the α2A and α2B adrenoceptors. Present study was conducted to determine the effects of centhaquin in a rat model of postoperative
Publikováno v:
Drug Research. 66:189-195
Manipulation of the central endothelin (ET) system via either ETA antagonists or ETB agonists following experimental cerebral ischemia has been shown to be beneficial in previous experimental studies. In order to further explore the involvement of th
Publikováno v:
Drug Research. 65:607-613
Endothelin, vascular endothelial growth factor and nerve growth factor play important roles in development of the central nervous system. ET(B) receptors have been shown to promote neurovascular remodeling in the adult ischemic brain through an incre
Autor:
Anil Gulati, Mary G. Leonard
Publikováno v:
Brain Research. 1528:28-41
Endothelin B receptor agonist, IRL-1620, has been shown in previous studies, conducted in our lab, to provide significant neuroprotection at both 24h and 1 week following permanent cerebral ischemia. It is possible that IRL-1620 may be neuroprotectiv
Publikováno v:
Critical Care Medicine. 40:1-328
Publikováno v:
Brain Research. 1464:14-23
We have earlier shown that stimulation of endothelin B receptors by IRL-1620 provides significant neuroprotection at 24 h following cerebral ischemia. However, the effect of IRL-1620 is not known in the subacute phase of cerebral ischemia, where deve
Publikováno v:
Brain Research. 1420:48-58
Endothelin and its receptors have long been considered therapeutic targets in the treatment of ischemic stroke. Recent studies indicate that ET(B) receptors may provide both vasodilatation and neuroprotection. The purpose of this study was to determi
Publikováno v:
Neuroscience. 301
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by severe cognitive impairment that ultimately leads to death. Endothelin (ET) and its receptors have been considered as therapeutic targets for AD. Recent studies in
Publikováno v:
Braindevelopment. 37(2)
Background: Endothelin (ET) plays an important role in many physiological functions. It has been demonstrated that endogenous ET-1 concentration in the central nervous system (CNS) changes with age; however the ontogeny of ETA and ETB receptors in th
Publikováno v:
Critical Care Medicine. 44:257-257